SCHEMBL8173581

SCHEMBL8173581

CC(C)(C)OC(=O)/C=C/c1ccc2c(c1)c1ccccc1n2Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 2/20 0.43
▸ PTGES2 Q9H7Z7 3/20 0.43
▸ PTGES O14684 1/20 0.43
▸ SERPINE1 P05121 1/20 0.42
▸ TSPO P30536 1/20 0.41
▸ HDAC6 Q9UBN7 4/20 0.40
▸ HDAC1 Q13547 3/20 0.40
▸ HDAC2 Q92769 2/20 0.40
▸ HDAC10 Q969S8 2/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ PLA2G2A P14555 1/20 0.40
▸ CYP19A1 P11511 1/20 0.39
▸ NR1H2 P55055 1/20 0.39
▸ PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8173584 1.00 NR1H4 (0.43) NR1H4PTGES2PTGESSERPINE1TSPO
SCHEMBL8173275 0.85 IP6K1 (0.47) TSPOHDAC6HDAC1HDAC2HDAC10
SCHEMBL8173273 0.85 IP6K1 (0.47) TSPOHDAC6HDAC1HDAC2HDAC10
SCHEMBL8156486 0.77 PTGER4 (0.55) TSPOHDAC6HDAC1HDAC10CYP19A1
SCHEMBL19244214 0.76 HDAC2 (0.54) NR1H4HDAC6HDAC1HDAC2NR1H2
SCHEMBL19244215 0.76 HDAC2 (0.54) NR1H4HDAC6HDAC1HDAC2NR1H2
SCHEMBL6732593 0.73 NR1H4 (0.50) NR1H4HDAC2HDAC8
SCHEMBL6732590 0.73 NR1H4 (0.50) NR1H4HDAC2HDAC8
SCHEMBL5362177 0.72 MEN1 (0.42) NR1H4PTGES2PLA2G2A
SCHEMBL5362181 0.72 MEN1 (0.42) NR1H4PTGES2PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043247-A A SUBSTITUTED ACRYLIC ACIDS FOR USE IN TREATMENT OF HUMAN AND ANIMAL DISORDERS, AND PURIFICATION OF PROTEINS OR GLYCOPROTEINS, AND TO THEIR USE IN DIAGNOSIS NOVO NORDISK A/S (DK) 2000-03-28 — — US disclosed
WO-1997039748-A1 MODULATORS OF MOLECULES WITH PHOSPHOTYROSINE RECOGNITION UNITS NOVO NORDISK A/S (DK) 1997-10-30 — — WO disclosed
Send feedback